2019 American Transplant Congress
Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts
1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ
*Purpose: New immunosuppressive agents in transplant should not only be efficacious but also help patients feel better (i.e. lower patient reported symptoms and improve health…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”
*Purpose: The recent increase in publications detailing discrimination and harassment in the medical setting has brought to light potential impairments of medical professional health and…2019 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation
*Purpose: Previous trials have not examined differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx) patients (pts).…2019 American Transplant Congress
Post-Donation Hypertension is Highly Associated with Estimated Nephron Number, Post-Donation Weight Gain, and Family History: A Prospective 5-Year Follow-Up after Living Kidney Donation
*Purpose: The rising prevalence of end-stage renal disease and chronic organ shortage subsequently calls more people upon to consider living kidney donation. Recent data, however,…2019 American Transplant Congress
Beyond Medication Education: Opportunities for Improvement in Health Education of Solid Organ Transplant Recipients
Department of Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: As immunosuppressive medications are crucial to graft and patient survival, transplant centers dedicate significant resources to medication education. However, patient outcomes also depend on…2018 American Transplant Congress
Quality of Life after Kidney Transplant in Andalucia (Spain)
Nephrology, Virgen de las Nieves University Hospital, Granada, Spain.
IntroductionKidney transplant remains the best option for patients with end-stage renal disease, offering patients a longer and more satisfying life. Quality of life, as defined…2018 American Transplant Congress
Associations among Physical Fitness/function, Pain and Depression in Kidney Transplant Patients
Kidney transplantation is the most successful treatment for end stage renal disease; however not all comorbidities of the disease are addressed by surgery. Depression and…2018 American Transplant Congress
Pregnancy Outcomes in Kidney Recipients with Lupus Nephritis
Lupus nephritis (LN) predominately affects females of childbearing age. This study aims to characterize pregnancy outcomes in kidney transplant recipients (KT) with LN compared to…2018 American Transplant Congress
Long-Term Social Outcome after Pediatric Kidney Transplantation
BackgroundPatients' and graft survival rates after pediatric kidney transplantation (KTx) were recently improved because of progress in immunosuppressants, perioperative care, and operative procedures. Therefore the…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 21
- Next Page »